Covered recipient · General Payments record
MESHA-GAY M BROWN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,041.79
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,327.10 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $574.71 | 5 |
| Medtronic, Inc. | $278.03 | 8 |
| LivaNova USA, Inc. | $261.31 | 3 |
| SK Life Science, Inc. | $213.05 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $150.28 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845205 | CMS |
| Abbott Laboratories | $75.00 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845207 | CMS |
| Abbott Laboratories | $180.79 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845209 | CMS |
| Abbott Laboratories | $150.38 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845211 | CMS |
| Abbott Laboratories | $18.26 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124845213 | CMS |
| LivaNova USA, Inc. | $141.51 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152800919 | CMS |
| LivaNova USA, Inc. | $29.39 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152800929 | CMS |
| LivaNova USA, Inc. | $90.41 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152801019 | CMS |
| Medtronic, Inc. | $161.31 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064118 | CMS |
| Medtronic, Inc. | $5.55 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064116 | CMS |
| Medtronic, Inc. | $38.81 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064120 | CMS |
| Medtronic, Inc. | $7.60 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064122 | CMS |
| Medtronic, Inc. | $13.28 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064126 | CMS |
| Medtronic, Inc. | $27.14 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064124 | CMS |
| Medtronic, Inc. | $7.47 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064128 | CMS |
| Medtronic, Inc. | $16.87 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117064130 | CMS |
| SK Life Science, Inc. | $107.25 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130935 | CMS |
| SK Life Science, Inc. | $20.00 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154131005 | CMS |
| SK Life Science, Inc. | $85.80 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154131001 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.